Jeffrey S. Hatfield

Jeffrey S. Hatfield has an estimated net worth of $8.34 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., Vir Biotechnology, Inc., ZAFGEN, INC., INVIVO THERAPEUTICS HOLDINGS CORP., aTYR PHARMA INC, Vitae Pharmaceuticals, Inc, and AMBIT BIOSCIENCES CORP.

2015 was Jeffrey S. Hatfield's most active year for acquiring shares with 8 total transactions. Jeffrey S. Hatfield's most active month to acquire stocks was the month of April. 2016 was Jeffrey S. Hatfield's most active year for disposing of shares, totalling 12 transactions. Jeffrey S. Hatfield's most active month to dispose stocks was the month of September. 2015 saw Jeffrey S. Hatfield paying a total of $315,106.90 for 172,810 shares, this is the most they've acquired in one year. In 2016 Jeffrey S. Hatfield cashed out on 743,732 shares for a total of $12,100,058.60, their largest year based on trade value.